South Korea · Pharmaceuticals
Pharmaceuticals
Biotechnology
Healthcare
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7
1999
Founded
Pharmaceuticals
Industry
South Korea
Location
14,204,701
Ranking
2,400 employees
Size

Get full access to view complete information

© Pubrio 2026